Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon
about
Treatment of hepatitis C in children: a systematic reviewGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theThe combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.Incidence of retinopathy in chronic hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapyRELATIONSHIP BETWEEN UVEITIS, DIFFERENT TYPES OF VIRAL HEPATITIS, AND LIVER CIRRHOSIS: A 12-Year Nationwide Population-Based Cohort Study.Chronic hepatitis C virus infection in children and adolescents: Epidemiology, natural history, and assessment of the safety and efficacy of combination therapy.Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review.New treatments for chronic hepatitis C: an overview for paediatricians.Hepatitis B and C.Pegylated IFN-α-2a and ribavirin in the treatment of hepatitis C infection in children.Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.
P2860
Q21136318-F336DDFA-F15D-4A8B-8B52-3F2D3EA3256FQ34212799-9A08CC41-753B-4519-92DF-34DAA7F00AF6Q34588247-C3734A46-847B-4A10-B756-3DFC57D5578AQ35277513-D9BD8604-46AA-4BBE-889D-7A70FDD686DDQ37529836-D264B9A8-1FAB-4E95-96EC-CEF12EFD7D01Q37561618-FA4BC472-3998-4349-9E75-078BB37B57FAQ37851006-579CC9A1-4410-4A95-B26A-1DBCCBC22058Q38126190-4F70C9C5-783E-4618-8A65-F999D129F8A9Q38282842-3117C190-C25C-4A81-AE4C-FC96C7F8366CQ39305112-6CBD0F49-C575-453A-A799-BABB9656E05BQ41535163-530ECA0A-F563-435E-AD7B-463ABF522708Q51842074-F50EA971-BA22-46C9-8745-D1C0303EDBF2
P2860
Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Ophthalmologic complications i ...... ated with pegylated interferon
@ast
Ophthalmologic complications i ...... ated with pegylated interferon
@en
Ophthalmologic complications i ...... ated with pegylated interferon
@nl
type
label
Ophthalmologic complications i ...... ated with pegylated interferon
@ast
Ophthalmologic complications i ...... ated with pegylated interferon
@en
Ophthalmologic complications i ...... ated with pegylated interferon
@nl
prefLabel
Ophthalmologic complications i ...... ated with pegylated interferon
@ast
Ophthalmologic complications i ...... ated with pegylated interferon
@en
Ophthalmologic complications i ...... ated with pegylated interferon
@nl
P2093
P2860
P1476
Ophthalmologic complications i ...... ated with pegylated interferon
@en
P2093
Kathleen B Schwarz
Michael R Narkewicz
Michael X Repka
PEDS-C Study Group
Philip Rosenthal
Todd Margolis
P2860
P304
P356
10.1097/MPG.0B013E3181B99CF0
P407
P50
P577
2010-08-01T00:00:00Z